Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Hydrofarm Holdings Group's Return on Invested Capital Insights

Benzinga Pro data, Hydrofarm Holdings Group (NASDAQ:HYFM) reported Q1 sales of $111.38 million. Earnings fell to a loss of $23.30 million, resulting in a 110.9% decrease from last quarter.

Why Nvidia Stock Is Falling

Why Nvidia Stock Is Falling

NVIDIA Corp (NASDAQ: NVDA) shares are trading lower Monday alongside several companies in the broader technology sector amid overall weakness as stocks continue to sell off following worse-than-expected May CPI data.

Why Apple Shares Are Sliding

Why Apple Shares Are Sliding

Apple Inc (NASDAQ: AAPL) shares are trading lower Monday alongside several companies in the broader technology sector amid overall weakness as stocks continue to sell off following worse-than-expected May CPI data.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

RBC Upgrades Tesla: EV Competition 'Doesn't Overly Concern Us'

Tesla Inc (NASDAQ: TSLA) shares dropped 3.3% on Monday despite the company landing an upgrade on Wall Street. The Analyst: RBC Capital Markets analyst Joseph Spak upgraded Tesla from Sector Perform to Outperform and cut his price target from $1,175 to $1,100.

Endo Inks US Pact For Osteoarthritis Pain Injectable

TLC BioSciences has entered a commercialization agreement with Endo International plc (NASDAQ:ENDP) for the U.S. rights of TLC599, a proprietary BioSeizer sustained-release injectable in Phase 3 development for osteoarthritis pain. Under the agreement signed with Endo's subsidiary Endo Ventures Limited (EVL), TLC will primarily be responsible for developing the product, and EVL for obtaining regulatory…

Gracell Reveals Encouraging Data From Pretreated Multiple Myeloma Patients

Gracell Biotechnologies Inc (NASDAQ:GRCL) announced the updated clinical data on GC012F, an autologous CAR-T therapeutic candidate dual-targeting B-cell maturation antigen (BCMA) and CD19, for relapsed/refractory multiple myeloma (RRMM). From October 2019 to January 2022, 29 heavily pretreated patients were enrolled and treated with a single infusion of GC012F at three dose levels (DL).…

Why Shares Of Astra Space Are Trading Lower

Astra Space, Inc. (NASDAQ: ASTR) shares are trading lower after the company failed to deliver NASA payloads to orbit.

inkl

Read news from The Economist, FT, and more,
with one subscription

Mid-Morning Market Update: Markets Open Lower; Dow Drops 600 Points

Mid-Morning Market Update: Markets Open Lower; Dow Drops 600 Points

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 600 points on Monday.

Here's The Bull, Bear Case For Microsoft Stock As Recession Fears Grip The Tech Sector

Here's The Bull, Bear Case For Microsoft Stock As Recession Fears Grip The Tech Sector

Microsoft Corporation (NASDAQ: MSFT) was trading about 2.5% lower in the premarket on Monday, in sympathy with the futures market, which was declining about 2.4%.

Why Electric Last Mile Solutions Stock Is Plunging

Why Electric Last Mile Solutions Stock Is Plunging

Electric Last Mile Solutions Inc (NASDAQ: ELMS) shares are trading significantly lower Monday after the company announced that it plans to file for bankruptcy.

Here's How Amazon Aims To Evade EU's Hefty Antitrust Penalties

Here's How Amazon Aims To Evade EU's Hefty Antitrust Penalties

Amazon.com, Inc (NASDAQ: AMZN) looks to share marketplace data with sellers and boost the visibility of rival products on its platform, Reuters reports.

Electro-Sensors Shares Pop On Its Merger With Mobile X Global

Electro-Sensors Shares Pop On Its Merger With Mobile X Global

Industrial monitoring systems firm Electro-Sensors, Inc (NASDAQ:ELSE) and Mobile X Global, Inc, a connectivity-as-a-service company, agreed to merge and re-name the combined company Mobile X Global, Inc. Mobile X Global, Inc will launch Mobile X, a new wireless brand positioned to disrupt the wireless industry. Shares of the company will likely trade on the…

Why This Qualcomm Analyst Is Raising Their Price Target For The Chipmaker

Why This Qualcomm Analyst Is Raising Their Price Target For The Chipmaker

Qualcomm, Inc. (NASDAQ: QCOM) shares have shed close to 27% year-to-date amid a broader market sell-off led by tech stocks. An analyst at KeyBanc Capital Markets is bracing up for more upside in the stock over the next 12 months.

GlobalFoundries-STMicro Discuss Partnering For Chip Plant In France

GlobalFoundries-STMicro Discuss Partnering For Chip Plant In France

GlobalFoundries Inc (NASDAQ:GFS) and STMicroelectronics N.V. (NYSE:STM) are amid discussions to build a semiconductor factory in France with the help of government funds, Bloomberg reports. The European Commission looks to produce 20% of the world’s chips by 2030. The European Union executive arm proposed the 43 billion euro ($45.3 billion) Chips Act earlier to…

Get all your
news in one place.

100's of premium titles.
One news app.

5 Analysts Have This to Say About First Solar

Analysts have provided the following ratings for First Solar (NASDAQ:FSLR) within the last quarter:

5 Analysts Have This to Say About TG Therapeutics

Analysts have provided the following ratings for TG Therapeutics (NASDAQ:TGTX) within the last quarter:

4 Analysts Have This to Say About Fulcrum Therapeutics

Within the last quarter, Fulcrum Therapeutics (NASDAQ:FULC) has observed the following analyst ratings:

Why Lensar Shares Are Trading Higher Today

The FDA granted 510(k) clearance to Lensar Inc's (NASDAQ:LNSR) next-generation ALLY Adaptive Cataract Treatment System (ALLY System). ALLY is the first FDA-cleared platform to enable cataract surgeons to complete the femtosecond-laser-assisted cataract surgery (FLACS) procedure seamlessly in a single, sterile environment. The company plans to deliver the first ALLY Systems to surgeons in Q3…

Get all your
news in one place.

100's of premium titles.
One news app.

Why Hillstream BioPharma Shares Are Trading Higher Today?

Hillstream BioPharma Inc (NASDAQ:HILS) shares are trading higher after it authorized a share repurchase program to acquire up to $1 million in common stock. As of March 31, Hillstream had approximately $11.1 million in cash and 11.4 million shares of common stock. "We have demonstrated strong execution and, as a result, have seen significant advancement…

What's Next For NRx Pharma As FDA Denies Breakthrough Therapy Tag For COVID-19 Therapy

The FDA has denied NRx Pharmaceuticals Inc's (NASDAQ:NRXP) Breakthrough Therapy designation (BTD) request for Zyesami (aviptadil). The request for BTD was submitted based on a post-hoc subgroup analysis of patients who, in addition to aviptadil or placebo, were also treated with Gilead Sciences Inc's (NASDAQ: GILD) remdesivir and whose respiratory failure due to critical COVID-19 continued…

Analyst Ratings for CRISPR Therapeutics

CRISPR Therapeutics (NASDAQ:CRSP) has observed the following analyst ratings within the last quarter:

5 Biotech Stocks To Watch During The Week Of June 13

Biotech stocks continued to be under pressure in the past week amid broader market weakness, precipitated by economic worries. Company-specific developments also triggered downward moves. Here's a compilation of five stocks that should be on your radar in the week of June 13: 1. Novavax

R Madhavan's 'Rocketry: The Nambi Effect' trailer launched at Times Square

Bollywood actor and filmmaker R Madhavan's biographical drama movie 'Rocketry: The Nambi Effect', which is based on the life of renowned scientist Nambi Narayanan, launched the trailer on the NASDAQ billboard at Times Square on Saturday.

What Tesla's 3-For-1 Split Means For The Battered Stock: 'A Smart Move By Board'

Tesla, Inc. (NASDAQ: TSLA) finally filed a proxy statement with the SEC, wherein it revealed that it intends to implement a 3-for-1 split in the form of a stock dividend.

As Meta gives Sheryl Sandberg a send-off, a probe underway on resource misappropriation

Sheryl Sandberg resigned from Meta Platforms Inc (NASDAQ: META) as COO last week after 14 years with the organization.

1 … 440 441 442 443

People

Sheryl Sandberg

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Intel Corporation

European Commission

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

387,296 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play